Yi Zhang | Health Sciences | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Yi Zhang | Health Sciences | Best Researcher Award 🏆

Director/Academic Vice President at Biotherapy Center, The First Affiliated Hospital of Zhengzhou University/Zhengzhou University School of Medical Sciences🎓

Prof. Yi Zhang is an internationally acclaimed expert in cell and tumor immunotherapy. Serving as Director of the Biotherapy Center at The First Affiliated Hospital of Zhengzhou University, he also holds key leadership roles, including Academic Vice President of the Zhengzhou University School of Medical Sciences and Director of the Zhongyuan Cellular and Immunotherapy Laboratory. With 35 years of research experience across Belgium, the U.S., and China, Prof. Zhang has pioneered breakthrough therapies, such as genetically engineered CAR-T cells for solid tumors, and holds 16 patents. His work has made significant impacts in reducing immune suppression and improving cancer treatment efficacy worldwide.

Professional Profile 

Education 🎓:

Prof. Yi Zhang has a profound academic foundation in medical sciences, gained through decades of experience and study in Belgium, the United States, and China. His extensive education and training have built the groundwork for his pioneering research in cell and tumor therapy.

Work Experience 💼:

Prof. Zhang is the Director of the Biotherapy Center at The First Affiliated Hospital of Zhengzhou University, where he also serves as the Academic Vice President for Zhengzhou University’s School of Medical Sciences and Director of the Zhongyuan Cellular and Immunotherapy Laboratory. Over a 35-year career, he has developed innovative therapies and led cutting-edge research in cell therapy, accumulating extensive clinical and academic expertise.

 

Skills 🔍

Known for his skills in genetically engineered cell therapies, Prof. Zhang is a leader in cellular engineering, particularly CAR-T cell technology. His groundbreaking work includes discovering a therapeutic target for solid tumors and developing gene-editing techniques to improve immune responses. His practical expertise in cell culture, immune cell enhancement, and patent development make him a pioneer in clinical biotherapeutics.

Awards and Honors 🏆

Prof. Zhang has received acclaim globally, being listed among the world’s top 100,000 scientists and recognized by both domestic and international peers for his contributions to immunotherapy. He has successfully converted seven patents, raising over 80 million RMB in transfer amounts, and is frequently invited to international conferences as a distinguished chair or guest of honor.

🤝 Memberships:

Prof. Zhang holds numerous prominent roles, such as Chairman of the Committee on Tumor Immunity and Biotherapy, Chinese Society of Immunology, and Deputy Chairman of the Cancer Biological Therapy Committee under the China Anti-Cancer Association. He also plays leadership roles in the Henan Anticancer Association and Henan Immunological Society, reflecting his commitment to advancing cell therapy on a national and global scale.

Teaching Experience 👩‍🏫:

Prof. Zhang has contributed significantly to training the next generation of scientists, collaborating with international colleagues to co-train PhD students and mentor young researchers. His commitment to academic growth is evident through his regular academic exchanges and collaborative projects with institutions in Canada, the U.S., and Europe.

Research Focus 🔬:

Prof. Zhang’s research is concentrated on tumor immunotherapy and cellular therapy, focusing on advancing CAR-T cell therapies for cancer. His achievements include creating novel immune cell treatments, reducing PD-1 expression to combat immune suppression, and conducting over 52 clinical trials for new cancer therapies, with 29 specifically targeting solid tumors.

Conclusion 

Prof. Yi Zhang stands as an exemplary candidate for the Best Researcher Award due to his substantial contributions to the field of cellular immunotherapy and cancer research. His achievements align closely with the award’s goals of recognizing innovation, impactful research, and contributions to society. With his strengths in pioneering therapy innovations and significant clinical applications, Prof. Zhang’s work exemplifies the award’s spirit, making him a distinguished candidate for the Best Researcher Award.

📚 Publilcation

  • “LFA-1 regulated by IL-2/STAT5 pathway boosts antitumor function of intratumoral CD8 + T cells for improving anti-PD-1 antibody therapy”
    • Year: 2024-12-31
    • Journal: OncoImmunology
  • “Characteristics and mechanisms of T‐cell senescence: A potential target for cancer immunotherapy”
    • Year: 2024-11
    • Journal: European Journal of Immunology
  • “CAR T Cells Engineered to Secrete IFNκ Induce Tumor Ferroptosis via an IFNAR/STAT1/ACSL4 Axis”
    • Year: 2024-10-03
    • Journal: Cancer Immunology Research
  • “A single-cell RNA-seq dataset describing macrophages in NSCLC tumor and peritumor tissues”
    • Year: 2024-10-01
    • Journal: Scientific Data
  • “Allogeneic CAR-T cells for cancer immunotherapy”
    • Year: 2024-09-24
    • Journal: Immunotherapy
  • “IL-24 improves efficacy of CAR-T cell therapy by targeting stemness of tumor cells”
    • Year: 2024-05-03
    • Journal: British Journal of Cancer
  • “Current advances in bacteria‐based cancer immunotherapy”
    • Year: 2024-02
    • Journal: European Journal of Immunology
  • “Emerging roles of plasmacytoid dendritic cell crosstalk in tumor immunity”
    • Year: 2023-10-09
    • Journal: Cancer Biology & Medicine
  • “Immunosenescence: molecular mechanisms and diseases”
    • Year: 2023-05-13
    • Journal: Signal Transduction and Targeted Therapy
  • “Overcoming resistance to immunotherapy by targeting GPR84 in myeloid-derived suppressor cells”
    • Year: 2023-04-28
    • Journal: Signal Transduction and Targeted Therapy

Dr.Bahareh Azimi | biomedical | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr.Bahareh Azimi | biomedical | Best Researcher Award

PhD Scholar at  Chitkara University, India

Dr. Bahareh Azimi is a distinguished researcher in the field of Textile Engineering, specializing in Textile Chemistry and Fiber Science. With a passion for advancing materials science applications in medicine, she focuses on developing innovative therapeutic strategies using polymeric nanofibers and nanoparticles. Her research is dedicated to improving health outcomes through cutting-edge technology and materials.

 

Professional Profile 

🎓 Education

Dr. Bahareh Azimi holds a Ph.D. in Textile Engineering with a focus on Textile Chemistry and Fiber Science from Amirkabir University of Technology, completed between September 23, 2010, and November 23, 2014, in Tehran, Iran. She also has an equivalent Ph.D. in Industrial Engineering (Curriculum in Chemistry and Materials Engineering) issued by the University of Pisa, Italy. Additionally, Dr. Azimi earned her Master’s Degree in Textile Engineering (Textile Chemistry and Fiber Science) from Amirkabir University of Technology from September 23, 2007, to October 24, 2009, and completed her Bachelor’s degree in the same field at the University of Yazd from September 23, 2003, to September 6, 2007.

🏢 Work Experience

Dr. Azimi is currently a postdoctoral researcher at the Department of Civil and Industrial Engineering at the University of Pisa since September 16, 2024. Her previous roles include a postdoctoral position in the Department of Surgical, Medical, Molecular, and Critical Area Pathology at the University of Pisa, where she focused on manufacturing and characterizing piezoelectric polymer nanofibers for cochlear implants. She has also worked on circular management of operating room waste in orthopedics and traumatology and has contributed to various projects involving the production of polymeric and composite nanofibers. Notably, she was a postdoctoral researcher at the Brazilian National Research Council, where she developed polymeric films with luminescent nanocrystals for dosimetric applications.

🧬 Skills

Dr. Azimi possesses advanced skills in electrospinning technology, materials characterization, and the development of biomimetic scaffolds. Her expertise extends to polymer and composite materials for tissue engineering applications, particularly in regenerative medicine. She is proficient in both experimental and theoretical methodologies, allowing her to address complex biomedical challenges effectively.

Awards and Honors 🏆

In 2024, Dr. Azimi received funding for her project titled “Artificial Intelligence Enabled Electrospinning Approach to Fight Pulmonary Cancer” through the Marie Skłodowska-Curie Actions-Seal of Excellence@UNIPI. This recognition underscores her innovative contributions to research and her commitment to addressing significant health challenges.

Membership 🤝

Dr. Azimi is an active member of various professional organizations related to Textile Engineering and materials science. Her memberships facilitate collaboration with peers and access to the latest advancements in her field, contributing to her continuous professional development.

Teaching Experience 📚

Dr. Azimi has experience in teaching and mentoring students in Textile Engineering, focusing on subjects related to textile chemistry and materials science. Her engaging teaching style and dedication to student success have made her a respected educator in her academic community.

🔬 Research Focus

Dr. Azimi’s current research includes developing biomimetic scaffolds for tissue regeneration, nanoparticle-mediated drug delivery systems for targeted therapy, and electroactive nanocomposites for electromechanical tissue engineering, particularly in the auditory system. She has been actively involved in nanomedicine, particularly exploring in vitro applications of piezoelectric ceramic nanomaterials such as zinc oxide, lithium niobate, and barium titanate nanoparticles, as well as their polymer composites for creating electrically sensitive cells. Her comprehensive research also addresses the development of devices from nano to macroscale, aimed at facilitating regeneration and modeling both normal and pathological tissues, with an emphasis on tissue engineering applied to electromechanically responsive tissues.

Conclusion 

Dr. Bahareh Azimi’s extensive research contributions, innovative methodologies, and dedication to advancing biomedical applications through materials science make her a strong candidate for the Best Researcher Award. Her work has the potential to significantly enhance health outcomes, particularly in the fields of tissue engineering and regenerative medicine. By addressing areas for improvement, such as public engagement and interdisciplinary collaboration, Dr. Azimi can further amplify her impact and leadership in research, reinforcing her candidacy for this prestigious recognition.

📚 Publication 

  • Antifouling Properties of Electrospun Polymeric Coatings Induced by Controlled Surface Morphology
    • Authors: Favrin, F.L., Zavagna, L., Sestini, M., Batoni, G., Danti, S.
    • Year: 2024
    • Journal: Energy and Environmental Materials
  • Electrospun Fiber-Based Tubular Structures as 3D Scaffolds to Generate In Vitro Models for Small Intestine
    • Authors: Zavagna, L., Canelli, E.F., Azimi, B., Milazzo, M., Danti, S.
    • Year: 2024
    • Journal: Macromolecular Materials and Engineering
  • Development and Characterization of Sodium Alginate-Based Bio-hybrid Super Absorbent Polymer with High Retention Capacity Suitable for Baby Diapers
    • Authors: Ismaeilimoghadam, S., Jonoobi, M., Hamzeh, Y., Seggiani, M., Danti, S.
    • Year: 2024
    • Journal: Journal of Polymers and the Environment
  • Piezoelectric Yield of Single Electrospun Poly(acrylonitrile) Ultrafine Fibers Studied by Piezoresponse Force Microscopy and Numerical Simulations
    • Authors: Montorsi, M., Zavagna, L., Scarpelli, L., Danti, S., Labardi, M.
    • Year: 2024
    • Journal: Polymers
  • Remnant polarization and structural arrangement in P(VDF-TrFE) electrospun fiber meshes affect osteogenic differentiation of human mesenchymal stromal cells
    • Authors: Azimi, B., Labardi, M., Sorayani Bafqi, M.S., Persano, L., Danti, S.
    • Year: 2024
    • Journal: Materials and Design
  • Recent advances in biomaterials for tissue-engineered constructs: Essential factors and engineering techniques
    • Authors: Norouzi, S., Saveh Shemshaki, N., Norouzi, E., Aboudzadeh, M.A., Bagherzadeh, R.
    • Year: 2024
    • Journal: Materials Today Chemistry
  • Bacterial Cellulose Electrospun Fiber Mesh Coated with Chitin Nanofibrils for Eardrum Repair
    • Authors: Azimi, B., Rasti, A., Fusco, A., Danti, S., Lazzeri, A.
    • Year: 2024
    • Journal: Tissue Engineering – Part A
  • Self-Powered Nanostructured Piezoelectric Filaments as Advanced Transducers for New Cochlear Implants
    • Authors: Mokhtari, F., Danti, S., Azimi, B., Varley, R.J., Razal, J.M.
    • Year: 2024
    • Journal: Energy and Environmental Materials
  • Emerging Multiscale Biofabrication Approaches for Bacteriotherapy
    • Authors: Rovelli, R., Cecchini, B., Zavagna, L., Batoni, G., Danti, S.
    • Year: 2024
    • Journal: Molecules
  • Application of Cellulose-Based Materials as Water Purification Filters; A State-of-the-Art Review
    • Authors: Azimi, B., Sepahvand, S., Ismaeilimoghadam, S., Jonoobi, M., Danti, S.
    • Year: 2024
    • Journal: Journal of Polymers and the Environment

Joanna Bartkowiak-Wieczorek | Pharmacology | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Joanna Bartkowiak-Wieczorek | Pharmacology | Best Researcher Award 🏆

Poznan University of Medical Sciences, Poland🎓

Dr.Joanna Bartkowiak-Wieczorek is an accomplished researcher and Assistant Professor at the Medical University of Karol Marcinkowski in Poznań, specializing in pharmacology and pharmacogenetics. With a strong focus on cannabinoids and their potential medical applications, particularly in oncology and personalized medicine, she has contributed significantly to understanding how genetic factors influence drug response. Joanna’s work has been recognized with the Best Researcher Award, reflecting her dedication to advancing pharmacological research and education. She is committed to bridging the gap between scientific inquiry and clinical practice, enhancing the safety and efficacy of pharmacotherapy for diverse patient populations.

 

Professional Profile 

 

🎓 Education

Joanna Bartkowiak-Wieczorek holds a Master of Science in Biological Sciences from Adam Mickiewicz University in Poznań, specializing in molecular biology. She completed her PhD at the Medical University of Poznań, focusing on epigenetic modifications in hybrids of green frogs and the polymorphism of genes associated with osteoporosis risk.

🏢 Work Experience

Since September 2018, she has served as an Assistant Professor at the Medical University of Karol Marcinkowski in Poznań, where she conducts research and teaches various programs in human physiology. Prior to this, she worked as scientific and technical staff at the Medical University of Poznań, conducting pharmacogenetic research and educational classes. She also held roles focused on quality management systems at the Institute of Natural Fibres and Medicinal Plants, contributing to the implementation of GMP and ISO standards.

 

Awards and Honors 🏆

Joanna has participated in various research projects funded by the National Science Centre, focusing on pharmacogenetics and the development of technologies for cannabinoid extraction for cancer treatment. Her contributions to scientific knowledge have been recognized through numerous publications in reputable journals, reflecting her commitment to advancing research in her field.

🔬 Research Focus

Joanna’s research primarily explores cannabinoids, their pharmacological properties, and applications in oncology and personalized medicine. She has conducted significant studies on the influence of individual genes on drug responses and has a strong background in pharmacogenetics, drug interactions, and the therapeutic potential of plant-based compounds.

Conclusion 

Joanna’s qualifications and achievements position her as a leading figure in her field, making her a suitable candidate for the Best Researcher Award. By addressing the identified areas for improvement, she could further enhance her research impact and continue to contribute to advancements in pharmacology and personalized medicine.

📚 Publilcation 

  1. Bartkowiak-Wieczorek, J., et al. (2024). Cannabis sativa L. Extract Alleviates Neuropathic Pain and Modulates CB1 and CB2 Receptor Expression in Rat. Biomolecules. DOI: 10.3390/biom14091065
  2. Bartkowiak-Wieczorek, J., et al. (2024). Methylsulfinyl Hexyl Isothiocyanate (6-MSITC) from Wasabi: A Promising Candidate for Cancer, Alzheimer’s Disease, and Obesity Treatment. Nutrients. DOI: 10.3390/nu16152509
  3. Bartkowiak-Wieczorek, J., et al. (2024). The Dual Faces of Oestrogen: The Impact of Exogenous Oestrogen on Physiological and Pathophysiological Functions of Tissues and Organs. International Journal of Molecular Sciences. DOI: 10.3390/ijms25158167
  4. Bartkowiak-Wieczorek, J., et al. (2024). Natural Products and Health. Nutrients. DOI: 10.3390/nu16030415
  5. Bartkowiak-Wieczorek, J. (2023). A Critical Look at New Possibilities of Therapeutic Use of Statins: A Summary of Current Knowledge. Farmacja Polska. DOI: 10.32383/farmpol/174070
  6. Bartkowiak-Wieczorek, J., et al. (2023). THC-Reduced Cannabis sativa L.—How Does the Solvent Determine the Bioavailability of Cannabinoids Given Orally?. Nutrients. DOI: 10.3390/nu15122646
  7. Bartkowiak-Wieczorek, J., et al. (2022). The Dark Side of Iron: The Relationship Between Iron, Inflammation, and Gut Microbiota in Diseases Associated with Iron Deficiency Anaemia. Nutrients. DOI: 10.3390/nu14173478
  8. Bartkowiak-Wieczorek, J. (2022). Polygraph Analyses: Technical and Practical Background. Journal of Medical Science. DOI: 10.20883/medical.e590
  9. Bartkowiak-Wieczorek, J., et al. (2021). High-Fat, Western-Style Diet, Systemic Inflammation, and Gut Microbiota: A Narrative Review. Cells. DOI: 10.3390/cells10113164
  10. Bartkowiak-Wieczorek, J., et al. (2020). Relationship Between Adipocytokines and Angiotensin-Converting Enzyme Gene Polymorphism in Lean Women with and without Polycystic Ovary Syndrome. Gynecological Endocrinology. DOI: 10.1080/09513590.2019.1695248
  11. Bartkowiak-Wieczorek, J., et al. (2020). Effect of Different Water Extracts from Platycodon grandiflorum on Pathogenesis of Chronic Bronchitis in Rats. Molecules. DOI: 10.3390/molecules25215020
  12. Bartkowiak-Wieczorek, J., et al. (2020). Effect of Genetic Variations for Interleukin-10 on Efficacy of Immunosuppressive Therapy in Kidney Transplant Patients. International Immunopharmacology. DOI: 10.1016/j.intimp.2020.107059
  13. Bartkowiak-Wieczorek, J. (2020). The MDR1/ABCB1 Gene Polymorphism in Colorectal Cancer. Archives of Medical Science. DOI: 10.5114/aoms.2017.70329
  14. Bartkowiak-Wieczorek, J., et al. (2019). Effect of MDR1 and CYP3A41B Polymorphisms on Cyclosporine-Based Immunosuppressive Therapy in Renal Transplant Patients*. Annals of Transplantation. DOI: 10.12659/AOT.914683
  15. Bartkowiak-Wieczorek, J. (2018). Demographic Factors Determining Folic Acid Supplementation in Pregnant and Childbearing-Age Women. Ginekologia Polska. DOI: 10.5603/GP.a2018.0036
  16. Bartkowiak-Wieczorek, J. (2018). Effect of Interleukin-6 Polymorphism on Renal Allograft Function and Immunosuppressive Therapy Efficacy. Farmacia. DOI: 10.31925/farmacia.2018.5.8
  17. Bartkowiak-Wieczorek, J., et al. (2018). Importance of New Generation Sequencing HLA Typing in Renal Transplantation—Preliminary Report. Transplantation Proceedings. DOI: 10.1016/j.transproceed.2018.05.005
  18. Bartkowiak-Wieczorek, J., et al. (2017). Effect of Salvia miltiorrhiza Root Extract on Brain Acetylcholinesterase, Butyrylcholinesterase Activities, mRNA Levels, and Memory in Rats. Physiology and Behavior. DOI: 10.1016/j.physbeh.2017.02.019
  19. Bartkowiak-Wieczorek, J. (2017). Role of the ITLN1 Gene Allelic Variant in Patients with Diabetic Foot. Polish Archives of Internal Medicine. DOI: 10.20452/pamw.4008
  20. Bartkowiak-Wieczorek, J., et al. (2017). Polymorphic Variants of Collagen 1A2 Gene in Osteopenia and Osteoporosis Development in Postmenopausal Women. Ginekologia Polska. DOI: 10.5603/GP.A2017.0077
  21. Bartkowiak-Wieczorek, J., et al. (2016). Analysis of Aldosterone Synthase and Atrial Natriuretic Peptide Gene Polymorphisms in Women with Preeclampsia. European Journal of Obstetrics and Gynecology and Reproductive Biology. DOI: 10.1016/j.ejogrb.2015.11.012
  22. Bartkowiak-Wieczorek, J. (2016). Association Between ACE Gene Polymorphism and Metabolic Disturbances in PCOS Women. Molecular Medicine Reports. DOI: 10.3892/mmr.2016.5910
  23. Bartkowiak-Wieczorek, J., et al. (2016). Influence of Melissa officinalis Leaf Extract on Long-Term Memory in Scopolamine Animal Model. Evidence-Based Complementary and Alternative Medicine. DOI: 10.1155/2016/9729818
  24. Bartkowiak-Wieczorek, J. (2016). Association Between Metabolic Syndrome Development in PCOS Patients and MTHFR Gene Polymorphism. Ginekologia Polska. DOI: 10.17772/gp/61751
  25. Bartkowiak-Wieczorek, J., et al. (2016). Antinociceptive and Anti-Inflammatory Effects of Oleanolic Acid and Aspirin Conjugate. Frontiers in Pharmacology. DOI: 10.3389/fphar.2016.00202
  26. Bartkowiak-Wieczorek, J. (2016). Importance of MDR1 Gene Polymorphisms in Colorectal Cancer Etiology. Przegląd Gastroenterologiczny. DOI: 10.5114/pg.2015.51185
  27. Bartkowiak-Wieczorek, J., et al. (2016). Influence of TNF-α Polymorphism on Immunosuppressive Therapy Efficacy in Kidney Transplant Patients. Journal of Physiology and Pharmacology.
  28. Bartkowiak-Wieczorek, J. (2016). Significance of Genetic Polymorphisms in the RANKL/RANK/OPG Signaling Pathway in Postmenopausal Osteoporosis. Ginekologia Polska. DOI: 10.5603/GP.2016.0014
  29. Bartkowiak-Wieczorek, J., et al. (2015). Analysis of ADIPOQ Gene Polymorphisms in Women with Excessive Weight Gain During Pregnancy. Ginekologia Polska. DOI: 10.17772/gp/2421
  30. Bartkowiak-Wieczorek, J., et al. (2015). Evaluation of Anti-Inflammatory and Analgesic Activities of Extracts from Chelidonium majus L. Herb. Central European Journal of Immunology. DOI: 10.5114/ceji.2015.54607
  31. Bartkowiak-Wieczorek, J. (2015). *Gender-Specific Implications for Pharmacology in Women of Child